Investors
Our pipeline of early stage health Innovations is creating economic, social and health impact. Our incubation program de-risks impact investment for global health technology and service companies. We provide investors with quality a pipeline which are investment ready.
Theory of Change
Sub-Saharan Africa accounts for 11% of the global population, but disproportionately bears 24% of the disease burden including 71% of infectious diseases, 21% of NCDs, and approximately half of the under-5 mortality rate. Yet Africa accounts for only 3% of pharma’s global revenues and 2% of medical devices global revenues. The challenge is not in the lack of technology or know-how to solve these problems, but the lack of a convincing business case to warrant the effort. We work with social entrepreneurs to develop and scale frugal innovations through sustainable business models to address Africa’s health problems.
Our Impact
We have worked with entrepreneurs across Kenya, Uganda and Ethiopia
Number of Jobs Created
Revenue Generated in Portfolio
Follow on Funding
Companies Supported
Number of Lives Reached
Number of Jobs Created
Number of Women Employed
Number of Women-led Innovators
Investors we have worked with











